ORGANOMETRIC INDICATORS OF LYMPHOID ORGANS IN RATSWITH DIFFERENT MODELS OF ALZHEIMER'S DISEASE
DOI: 10.17721/1728.2748.2023.95.32-38
Keywords:
Alzheimer's disease, neuroinflammation, lymphoid organs, thymus, spleenAbstract
B a c k g r o u n d . Alzheimer's disease is a progressive neurodegenerative disorder that affects millions of people worldwide. Increasing evidence suggests that antigens of the central nervous system can interact with lymphocytes and antigen-presenting cells through meningeal lymphatic pathways, indicating that both innate and adaptive immune responses may play a role in the development of neurodegenerative diseases. Thymic involution, a characteristic of aging immune systems, leads to a reduction in naive T lymphocyte production, affecting adaptive immune responses and resulting in compromised immune surveillance. Ineffective immune response triggers neurodegeneration through prolonged activation of immune cells, a key characteristic of the disease. The aim of this study was to comparatively assess the reaction of lymphoid organs in rats with two widely used intervention models of Alzheimer's disease induced by intrahippocampal administration of Aβ1-40 and Aβ25-35.
M e t h o d s . Male Wistar rats were used in the experiments, including intact and sham-operated animals as controls. Disease progression was confirmed through feeding behavior, body and organ weight measurements, evaluation of cognitive impairments in the Barnes maze behavioral test, and assessment of dopaminergic neuron loss. Hematological parameters were analyzed at the end of the experiment (day 37), including the relative quantity of lymphocytes. Spearman's correlation analysis was performed between organometric indicators of the thymus and spleen and quantitative changes in circulating lymphocytes in animals with different Alzheimer's disease models.
R e s u l t s . In rats with Aβ1-40-induced Alzheimer's disease, an increase in splenic index was observed, indicating moderate splenomegaly. A statistically significant increase in the absolute quantity of lymphocytes with a decrease in their relative quantity and marked monocytosis was recorded. There was a strong negative correlation between splenic index and the quantity of circulating lymphocytes. Animals with Aβ25-35-induced Alzheimer's disease did not show differences in splenic index compared to control groups.
C o n c l u s I o n s . The development of Alzheimer's disease is accompanied by changes in the weight indices of lymphatic organs involved in antigen presentation and the generation of adaptive immune responses, as well as in the clearance of antigenic material from the brain. Disruptions in correlation links between quantitative characteristics of circulating lymphocytes and weight indices of primary and secondary lymphoid organs may be associated with disturbances in immunopoiesis and immunogenesis.
References
Aspelund, A., Antila, S., Proulx, S. T., Karlsen, T. V., Karaman, S., Detmar, M., Wiig, H., & Alitalo, K. (2015). A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. Journal of Experimental Medicine, 212(7), 991–999. https://doi.org/10.1084/jem.20142290
Baazim, H., Antonio-Herrera, L., & Bergthaler, A. (2021). The interplay of immunology and cachexia in infection and cancer. Nature Reviews Immunology. https://doi.org/10.1038/s41577-021-00624-w
Berrón-Ruíz, L., López-Herrera, G., Ávalos-Martínez, C. E., Valenzuela- Ponce, C., Ramírez-San Juan, E., Santoyo-Sánchez, G., Mújica Guzmán, F., Espinosa-Rosales, F. J., & Santos-Argumedo, L. (2016). Variations of B cell subpopulations in peripheral blood of healthy Mexican population according to age: Relevance for diagnosis of primary immunodeficiencies. Allergologia Et Immunopathologia, 44(6), 571–579. https://doi.org/10.1016/ j.aller.2016.05.003
Canet, G., Zussy, C., Hernandez, C., Maurice, T., Desrumaux, C., & Givalois, L. (2023). The pathomimetic oAβ25–35 model of Alzheimer's disease: Potential for screening of new therapeutic agents. Pharmacology & Therapeutics, 108398. https://doi.org/10.1016/j.pharmthera.2023.108398
Ding, D., Wang, X., Li, Q., Li, L., & Wu, J. (2021). Research on the glial– lymphatic system and its relationship with alzheimer's disease. Frontiers in Neuroscience, 15. https://doi.org/10.3389/fnins.2021.605586
Guo, L., Li, X., Gould, T., Wang, Z.-Y., & Cao, W. (2023). T-cell aging and Alzheimer's disease. Frontiers in Immunology, 14. https://doi.org/10.3389/ fimmu.2023.1154699
Louveau, A., Herz, J., Alme, M. N., Salvador, A. F., Dong, M. Q.,
Viar, K. E., Herod, S. G., Knopp, J., Setliff, J. C., Lupi, A. L., Da Mesquita, S.,
Frost, E. L., Gaultier, A., Harris, T. H., Cao, R., Hu, S., Lukens, J. R., Smirnov, I., Overall, C. C., . . . Kipnis, J. (2018). CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nature Neuroscience, 21(10), 1380–1391. https://doi.org/10.1038/s41593-018-0227-9
Mesquita, S. D., Louveau, A., Vaccari, A., Smirnov, I., Cornelison, R. C., Kingsmore, K. M., Contarino, C., Onengut-Gumuscu, S., Farber, E., Raper, D., Viar, K. E., Powell, R. D., Baker, W., Dabhi, N., Bai, R., Cao, R., Hu, S., Rich, S. S., Munson, J. M., . . . Kipnis, J. (2018). Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease. Nature, 560(7717), 185–191. https://doi.org/10.1038/s41586-018-0368-8
Mesquita, S. D., Papadopoulos, Z., Dykstra, T., Brase, L., Farias, F., Wall, M., Jiang, H., Kodira, C. D., De Lima, K. A., Herz, J., Louveau, A., Goldman, D. H., Salvador, A. F., Önengüt-Gümüşcü, S., Farber, E., Dabhi, N., Kennedy, T., Milam, M. G., Baker, W., . . . Kipnis, J. (2021). Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy. Nature, 593(7858), 255–260. https://doi.org/10.1038/s41586-021-03489-0
Minaglia, C., Giannotti, C., Boccardi, V., Mecocci, P., Serafini, G., Odetti, P., & Monacelli, F. (2019). Cachexia and advanced dementia. Journal of Cachexia, Sarcopenia and Muscle, 10(2), 263–277. https://doi.org/ 10.1002/jcsm.12380
Muntsant, A., & Giménez-Llort, L. (2022). Crosstalk of Alzheimer's disease-phenotype, HPA axis, splenic oxidative stress and frailty in late- stages of dementia, with special concerns on the effects of social isolation: A translational neuroscience approach. Frontiers in Aging Neuroscience, 14. https://doi.org/10.3389/fnagi.2022.969381
Natale, G., Limanaqi, F., Busceti, C. L., Mastroiacovo, F., Nicoletti, F., & Puglisi-Allegra, S. (2021). Glymphatic system as a gateway to connect neurodegeneration from periphery to CNS. Frontiers in Neuroscience, 15. https://doi.org/10.3389/fnins.2021.639140
Nefedova, A. (2023). Microglial phagocytosis in rats with different models of alzheimer's disease. Biotechnologia Acta, 16(1), 57–66. https://doi.org/ 10.15407/biotech16.01.057
Nefodova, A., Rudyk, M., Pasichnichenko, M., Dovhyi, R., Dovbynchuk, T., Tolstanova, G., & Skivka, L. (2022). Pro-inflammatory effects of placebo neurosurgery in rats: age-related features. General Surgery, 2, 56–63. https://doi.org/10.30978/gs-2022-2-56
Peng, H. B., Noh, K., Pan, S. R., Saldivia, V., Serson, S., Toscan, A., de Lannoy, I. A. M., & Pang, K. S. (2020). Human Amyloid-β40 Kinetics after Intravenous and Intracerebroventricular Injections and Calcitriol Treatment in Rats In Vivo. Drug Metabolism and Disposition, 48(10), 944–955. https://doi.org/10.1124/dmd.120.090886
Rostagno, A. A. (2022). Pathogenesis of Alzheimer's Disease. International Journal of Molecular Sciences, 24(1), 107. https://doi.org/ 10.3390/ijms24010107
Wu, K.-M., Zhang, Y.-R., Huang, Y.-Y., Dong, Q., Tan, L., & Yu, J.-T.
(2021a). The role of the immune system in Alzheimer's disease. Ageing Research Reviews, 70, 101409. https://doi.org/10.1016/j.arr.2021.101409
Yu, Z., Chen, D., Tan, C., Zeng, G., He, C., Wang, J., Bu, X., & Wang, Y. (2021). Physiological clearance of Aβ by spleen and splenectomy aggravates Alzheimer‐type pathogenesis. Aging Cell, 21(1). https://doi.org/10.1111/ acel.13533
Zhang, Y., Wang, J., Chen, S., Wang, H., Li, Y., Ou, Y., Huang, S., Chen, S., Cheng, W., Feng, J., Dong, Q., & Yu, J. (2022). Peripheral immunity is associated with the risk of incident dementia. Molecular Psychiatry, 27(4), 1956–1962. https://doi.org/10.1038/s41380-022-01446-5
